- “Bambudil (Bambuterol)” already exists in your wishlist
Asthalin Inhaler (Salbutamol)
Price range: $30.00 through $90.00
| Active Ingredient | Salbutamol |
|---|---|
| Manufacturer | Cipla Limited |
| Packaging | 200 MDI in 1 Inhaler |
| Strength | 100mcg |
| Delivery Time | 6 To 15 days |
| SKU: | Asthalin Inhaler (Salbutamol) |
Asthalin Inhaler — Complete Product Description:-
Overview:-
Asthalin Inhaler is one of India’s most widely recognized and trusted rescue bronchodilators — a fast-acting, prescription-based pressurized Metered-Dose Inhaler (MDI) that delivers immediate relief from the sudden and distressing symptoms of asthma and chronic obstructive pulmonary disease (COPD). Manufactured by Cipla Ltd. — one of India’s most respected and globally celebrated pharmaceutical companies — Asthalin Inhaler has earned its place as a cornerstone of respiratory care, relied upon by millions of patients, prescribed by respiratory specialists, and recommended by general practitioners across India and internationally.
Each actuation of Asthalin Inhaler delivers a precisely measured dose of 100 mcg of Salbutamol Sulphate directly into the lungs, and the inhaler comes preloaded with 200 metered doses, making it a dependable, long-lasting companion for anyone living with a reversible obstructive airway condition. Its iconic light blue compact design is universally recognizable among respiratory patients worldwide — small enough to slip into a pocket or handbag, yet powerful enough to reverse an acute asthma attack within minutes.
Asthalin Inhaler is classified as a fast-acting bronchodilator or “reliever” inhaler — used on demand when breathing difficulties arise, rather than on a fixed daily schedule. It is the inhaler patients reach for when wheezing begins, when the chest tightens unexpectedly, or when breathlessness makes speaking, eating, or sleeping difficult. In most comprehensive asthma treatment plans, Asthalin Inhaler serves as the rescue component alongside a separate daily “preventer” inhaler — typically an inhaled corticosteroid — which manages the underlying airway inflammation.
The formulation is CFC-free, using the environmentally responsible propellant HFA 134a (Norflurane), reflecting Cipla’s commitment to both patient health and environmental stewardship.
Active Ingredient
Asthalin Inhaler contains Salbutamol Sulphate — 100 mcg per actuation — as its sole active pharmaceutical ingredient. Salbutamol, also known internationally as Albuterol, is one of the most extensively studied and clinically established bronchodilators in the history of respiratory medicine. It belongs to the class of selective beta-2 adrenergic receptor agonists — medicines that act specifically on the receptors located in the smooth muscle of the bronchial airways, triggering rapid relaxation and widening of the breathing passages.
Salbutamol has been in clinical use for several decades and remains the global gold standard for fast-acting bronchodilator therapy. Its well-understood mechanism, rapid onset, proven safety record, and broad clinical applicability across age groups make it the active ingredient of choice in rescue inhaler therapy worldwide. Asthalin Inhaler delivers this proven molecule in an efficient, portable, and reliable CFC-free pressurized MDI format.
How It Works — Mechanism of Action?
Salbutamol works by selectively binding to the beta-2 adrenergic receptors present on the surface of smooth muscle cells that surround the bronchial airways throughout the lungs. Upon binding, it stimulates the enzyme adenylate cyclase, which catalyzes the conversion of adenosine triphosphate (ATP) into cyclic adenosine monophosphate (cAMP). The resulting rise in intracellular cAMP levels activates protein kinase A — an enzyme that prevents the phosphorylation of myosin and reduces the intracellular calcium concentration, both of which are necessary triggers for smooth muscle contraction.
The net result of this cascade is rapid, potent relaxation of the bronchial smooth muscle. Constricted, narrowed airways begin to widen within minutes of inhalation, airflow resistance drops significantly, and the sensation of chest tightness, wheeze, and breathlessness eases quickly and meaningfully. In addition, Salbutamol inhibits the release of bronchoconstricting mediators — including histamine and leukotrienes — from sensitized mast cells in the airway lining, providing an additional protective layer against acute airway narrowing.
Bronchodilation with Asthalin Inhaler begins within 5 minutes of inhalation, reaches its peak effect within 30 to 60 minutes, and the therapeutic benefit lasts for 4 to 6 hours — providing a meaningful and reliable window of respiratory relief.
Therapeutic Uses
Asthalin Inhaler is indicated for the treatment and prevention of a range of obstructive and reversible airway conditions.
1. Acute Asthma Relief Asthma causes recurrent episodes of airway narrowing, inflammation, and hypersensitivity in response to triggers — including allergens, tobacco smoke, cold air, exercise, dust, pet dander, mould, and respiratory infections — producing wheezing, coughing, chest tightness, and acute shortness of breath. Asthalin Inhaler provides fast, effective bronchodilation during these acute episodes, rapidly reversing the airway narrowing, easing breathing, and helping the patient regain control of their respiratory function within minutes of use.
2. Chronic Obstructive Pulmonary Disease (COPD) COPD — encompassing chronic bronchitis and emphysema — is a progressive, long-term lung condition characterized by persistent airway inflammation, obstruction, and difficulty moving air in and out of the lungs. Asthalin Inhaler provides valuable relief from the acute exacerbations and day-to-day breathlessness, wheezing, and chronic cough that characterize COPD, significantly improving the patient’s ability to carry out everyday activities.
3. Prevention of Exercise-Induced Bronchospasm For patients whose airways constrict during or after physical activity — a condition known as exercise-induced bronchospasm — Asthalin Inhaler can be used as a preventive measure before exercise. When taken 10 to 15 minutes before physical exertion, it helps maintain open airways throughout the activity and significantly reduces the likelihood of bronchospasm occurring.
4. Prevention of Trigger-Induced Bronchospasm Beyond exercise, Asthalin Inhaler can be used prophylactically before anticipated exposure to known asthma triggers — such as allergens, cold environments, or occupational irritants — to prevent the onset of bronchospasm and preemptively protect the airways.
5. Management of Chronic Respiratory Conditions Asthalin Inhaler can form part of a broader, long-term treatment plan for chronic respiratory conditions, helping to control symptoms and improve lung function alongside a daily preventer therapy prescribed by a doctor.
Who Can Use an Asthalin Inhaler?
Asthalin Inhaler is indicated for use in adults, adolescents, and children aged four years and above for the relief and prevention of bronchospasm associated with asthma and COPD. It is not recommended for children below four years of age, as clinical safety and efficacy data have not been fully established for this age group. Elderly patients may use an Asthalin Inhaler under medical guidance, though closer monitoring is advisable given their potential increased sensitivity to cardiovascular side effects. Patients with known hypersensitivity to Salbutamol Sulphate or any other component of the inhaler formulation should not use this product.
Explore More Asthma Inhaler Guides:- Asthma Inhalers: Types, Uses, Benefits & Complete Treatment Guide.
Dosage & Administration
Asthalin Inhaler should be used exactly as prescribed by a qualified doctor. It is intended for use as required — when symptoms arise — rather than as a regular, fixed-schedule medication. The dose and frequency will depend on the patient’s age, clinical condition, severity of symptoms, and overall treatment plan.
Standard Dosage Guidelines:
For the relief of acute symptoms such as wheezing and shortness of breath in adults and adolescents, one to two puffs are typically recommended as needed. For the prevention of exercise-induced or trigger-induced bronchospasm, two puffs are usually taken 10 to 15 minutes before exercise or anticipated exposure to a trigger. For regular symptomatic treatment, up to two puffs may be taken up to four times a day. The inhaler should be used as required rather than on a rigid regular schedule.
If Asthalin Inhaler is needed more than three times a week for symptom relief — outside of exercise prevention — this is a signal that the underlying asthma may not be adequately controlled and a medical review is strongly advised. The doctor may recommend starting or increasing a preventer therapy such as an inhaled corticosteroid.
How to Use the Metered-Dose Inhaler (MDI):
- Remove the mouthpiece cover and inspect it for any debris or blockage.
- Before first use — or if the inhaler has not been used for several days — prime it by releasing 2 to 3 test puffs into the air to ensure accurate dosing.
- Shake the inhaler vigorously for at least 5 seconds before each use to ensure the medication is evenly mixed within the canister.
- Hold the inhaler upright throughout, with the mouthpiece pointing downward.
- Breathe out gently and fully to empty your lungs before inhaling.
- Place the mouthpiece between your teeth and close your lips tightly around it, forming a firm airtight seal — ensure your tongue does not block the opening.
- Begin to breathe in slowly and steadily through your mouth, and simultaneously press down firmly on the canister once to release one measured dose.
- Continue breathing in as deeply as possible, drawing the medication as far into the lungs as you can.
- Remove the inhaler from your mouth and hold your breath for approximately 10 seconds — or as long as comfortably possible — to allow the medication to settle deeply and evenly throughout the airways.
- Exhale slowly and gently through the nose.
- If a second puff is required, wait at least 30 seconds before repeating steps 3 through 10.
- Replace the mouthpiece cover securely after every use.
For patients who find it difficult to coordinate inhalation with canister actuation — particularly young children, the elderly, and those in acute respiratory distress — a spacer device can be used alongside Asthalin Inhaler. The spacer holds the cloud of medication momentarily, allowing the patient to inhale it more slowly and effectively, significantly improving lung deposition and reducing wastage. Consult your doctor or pharmacist for guidance on choosing and using an appropriate spacer.
It is best to wait a few minutes after using the inhaler before drinking water, to allow the medication to absorb fully into the airways.
Inhaler Cleaning Instructions
Regular cleaning of the Asthalin Inhaler is essential to prevent blockage of the actuator orifice, which can reduce the amount of medication delivered per puff. The inhaler should be cleaned at least once a week as follows:
Remove the metal canister from the plastic actuator and take off the mouthpiece cover. Rinse the plastic actuator, mouthpiece, and cover under running tap water, ensuring the water passes through the actuator from both ends to confirm the orifice is clear and unblocked. Do not place the metal canister in water or clean it with water under any circumstances. Allow the plastic components to dry thoroughly in a warm place before reassembling — avoid drying near direct or excessive heat sources. Never use harsh detergents, solvents, or abrasive materials on any part of the inhaler.
Side Effects
Asthalin Inhaler is generally safe and well-tolerated when used as directed. Common side effects include fine tremors — particularly of the hands — nervousness, restlessness, headache, nausea, vomiting, dry mouth, dryness or soreness of the throat, dizziness, increased heart rate, and nasal congestion. These side effects are usually mild, temporary, and tend to resolve on their own as the body adjusts to the medication.
More serious side effects that require prompt medical attention include chest pain, a very rapid or noticeably irregular heartbeat, severe or persistent dizziness, seizures, extreme nervousness, uncontrollable shaking, difficulty sleeping, and swelling of the face, lips, tongue, or throat, indicating a severe allergic reaction. If any of these occur, the use of the inhaler should be stopped immediately, and medical help should be sought without delay.
Paradoxical bronchospasm — a rare but important adverse reaction where the airways constrict rather than relax immediately after use — can occasionally occur. If breathing becomes more difficult right after using the Asthalin Inhaler, the medication must be stopped at once and urgent medical attention must be sought.
Overdose symptoms include severe tremors, intense headache, chest pain, extreme nervousness, rapid or irregular heartbeat, dry mouth, nausea, dizziness, and, in serious cases, seizures. Seek emergency medical care immediately if an overdose is suspected.
Precautions & Warnings
Before using Asthalin Inhaler, patients must inform their doctor about all existing medical conditions — particularly high blood pressure, heart disease or cardiac arrhythmias, overactive thyroid gland (hyperthyroidism), diabetes, low blood potassium levels (hypokalemia), liver or kidney problems, stomach ulcers, or seizure disorders.
Asthalin Inhaler may lower blood potassium levels, increasing the risk of cardiac arrhythmias — an effect that can be worsened when used alongside xanthine derivatives, steroids, diuretics, or long-term laxatives. Patients with pre-existing low potassium should use this inhaler with particular caution and under close medical monitoring.
Blood glucose levels may rise with use, requiring diabetic patients to monitor their levels closely and inform their doctor of any significant changes.
Patients scheduled for surgery involving halogenated anaesthetics should inform their surgeon and anaesthesiologist that they are using Salbutamol, as it is recommended to discontinue use at least 6 hours before such a procedure, where possible. The inhaler contains a small amount of ethanol, which may rarely cause a reaction in patients taking Disulfiram or Metronidazole.
Asthalin Inhaler does not typically impair the ability to drive. However, as it can occasionally cause dizziness, patients who experience this symptom should not drive or operate heavy machinery until they feel fully recovered.
Smoking must be strictly avoided throughout the course of treatment, as it causes progressive lung damage and directly undermines the effectiveness of bronchodilator therapy. Alcohol consumption should be discussed with a doctor, while there is no known major interaction, excessive alcohol use is inadvisable in patients with chronic respiratory conditions.
Patients should be advised not to stop using the Asthalin Inhaler abruptly without consulting their doctor. If symptoms appear to have improved, this does not mean the inhaler is no longer needed — a doctor’s guidance is required before any changes to the treatment plan are made.
During pregnancy, Asthalin Inhaler should only be used when clearly necessary and under direct medical supervision. Safety in pregnant women has not been fully established through controlled clinical trials. During breastfeeding, use should be discussed with a doctor, as the extent to which Salbutamol passes into breast milk in clinically significant quantities remains a matter of individual clinical assessment.
Drug Interactions
Patients should provide their doctor with a complete list of all medications, supplements, vitamins, and herbal products they are currently taking before using Asthalin Inhaler. Beta-blockers — including Metoprolol Succinate, Propranolol, Atenolol, and Labetalol — may reduce or block the bronchodilatory effect of Salbutamol and should generally be avoided in asthma patients. Diuretics such as Furosemide and Hydrochlorothiazide can compound the potassium-lowering effect of Salbutamol, increasing the risk of hypokalemia. Xanthine derivatives such as Theophylline and Aminophylline, used concurrently, may also worsen hypokalemia. Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants may intensify the cardiovascular effects of the drug. Other sympathomimetic agents and adrenergic agonists may amplify side effects when used alongside Salbutamol. Patients taking Disulfiram or Metronidazole should exercise caution given the small ethanol content in the inhaler formulation.
Storage Instructions
Store Asthalin Inhaler at room temperature, below 30°C, away from direct sunlight, heat sources, and moisture. Do not refrigerate or freeze the canister, as cold temperatures can reduce delivery consistency. Keep the inhaler away from open flames, as the contents are under pressure and the canister is flammable. Always keep the inhaler upright during both storage and use. Replace the mouthpiece cover after every use. Check the expiry date printed on the canister before each use and replace the inhaler once expired or when all 200 doses have been fully delivered. Keep out of the reach and sight of children and pets at all times.
Asthalin Inhaler vs. Levolin Inhaler — Understanding the Difference
Both Asthalin Inhaler and Levolin Inhaler are fast-acting rescue bronchodilators made by Cipla Ltd. and used for the relief of asthma and COPD symptoms. The key difference lies in their active ingredient. Asthalin Inhaler contains conventional Salbutamol — a racemic mixture of both the active R-form and the inactive S-form — at 100 mcg per puff. Levolin Inhaler contains Levosalbutamol — the purified R-enantiomer alone — at 50 mcg per puff. Because Levosalbutamol is the pharmacologically active component, a lower dose achieves comparable bronchodilation, potentially with fewer side effects attributed to the inactive S-isomer. Your doctor will determine which molecule and formulation is most appropriate for your clinical needs and individual response to therapy.
Why Choose Asthalin Inhaler?
Asthalin Inhaler combines decades of clinical trust with everyday practicality. Its compact, lightweight design ensures that fast-acting rescue bronchodilation is always accessible — at home, at work, in the classroom, or anywhere life takes a patient. Its 200-dose CFC-free canister is environmentally responsible, cost-effective, and long-lasting. Salbutamol’s well-established safety profile, broad age-group applicability, rapid onset, and proven efficacy across the full spectrum of obstructive airway disease make Asthalin Inhaler an enduring and irreplaceable tool in respiratory care.
Backed by Cipla’s unmatched legacy in respiratory pharmaceutical innovation and trusted by patients and healthcare professionals across India and around the world, Asthalin Inhaler remains the gold-standard rescue inhaler for those who need reliable, rapid, and effective airway relief — exactly when and where they need it most.
Always use Asthalin Inhaler under the guidance of a qualified medical professional. This product is available on prescription only.
Disclaimer:-
This product description is intended for informational and educational purposes only and does not constitute medical advice. Please consult your doctor or pharmacist before starting, stopping, or making any changes to your medication.
Related Brands:-
Additional information
| unit | 3 Inhaler, 5 Inhaler, 10 Inhaler |
|---|









Reviews
There are no reviews yet.